Financial report interval: 2025.12.31 - 2026.03.31
Preview: huahaipharm(600521) predict that the Revenue is 2.335 B (-1.4%);the EBIT is 444.14 M (+17.88%);the EPS is 0.27 (+28.57%), Beat estimate.